안구건조증 치료 기기 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2031년)

Persistence Market Research has recently released a comprehensive report on the global market for dry eye disease (DED) treatment devices. This report provides an in-depth analysis of crucial market dynamics, including drivers, trends, opportunities, and challenges, offering detailed insights into the market structure.

Key Insights:

• Dry Eye Disease Treatment Devices Market Size (2024E): US$212.3 Mn
• Projected Market Value (2031F): US$345.1 Mn
• Global Market Growth Rate (CAGR 2024 to 2031): 6.2%

Dry Eye Disease Treatment Devices Market - Report Scope:

Dry eye disease treatment devices are integral to managing symptoms of dry eye disease, a condition characterized by inadequate tear production or poor tear quality. These devices include a range of technologies such as punctal plugs, thermal pulsation systems, and intense pulsed light (IPL) devices, which aim to alleviate symptoms, improve tear production, and enhance patient comfort. The market serves various settings including ophthalmology clinics, hospitals, and homecare environments, offering solutions that cater to different severities and types of dry eye disease.

Market Growth Drivers:

The global dry eye disease treatment devices market is driven by several key factors. Increasing prevalence of dry eye disease, spurred by rising screen time, environmental factors, and aging populations, is a significant growth driver. Advances in treatment technology, including improved punctal plug designs and the development of sophisticated thermal pulsation and IPL devices, contribute to enhanced treatment efficacy and patient satisfaction. Additionally, growing awareness about dry eye disease and the availability of more advanced and patient-friendly treatment options further fuel market expansion.

Market Restraints:

Despite promising growth prospects, the dry eye disease treatment devices market faces challenges. High treatment costs and limited insurance coverage can restrict patient access and adoption rates, particularly in emerging economies with constrained healthcare budgets. Regulatory hurdles and the need for clinical validation of new technologies can also impact market growth. Addressing these issues requires collaboration between manufacturers, healthcare providers, and policymakers to improve accessibility and affordability of dry eye disease treatment solutions.

Market Opportunities:

The dry eye disease treatment devices market presents significant opportunities driven by technological advancements and evolving healthcare practices. The integration of digital health technologies, such as mobile apps for symptom tracking and telemedicine consultations, enhances patient engagement and adherence to treatment protocols. Moreover, expanding applications of treatment devices beyond traditional uses, such as for managing severe cases of dry eye disease and associated conditions, open new avenues for market growth. Strategic partnerships, ongoing R&D, and innovation in device design and functionality are crucial to capitalizing on these opportunities and maintaining a competitive edge in the market.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the dry eye disease treatment devices market globally?
• Which types of devices and treatment methods are leading adoption across different healthcare settings?
• How are technological advancements reshaping the competitive landscape of the dry eye disease treatment devices market?
• Who are the key players contributing to the dry eye disease treatment devices market, and what strategies are they employing to stay relevant?
• What are the emerging trends and future prospects in the global dry eye disease treatment devices market?

Competitive Intelligence and Business Strategy:

Leading players in the global dry eye disease treatment devices market, including Allergan plc, Johnson & Johnson Vision, and TearLab Corporation, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced treatment devices, such as next-generation thermal pulsation systems and enhanced punctal plugs. Collaborations with healthcare providers and investment in marketing and education programs foster market growth and improve patient outcomes. Additionally, emphasis on clinical research and evidence-based practices supports market expansion and drives innovation in the dry eye disease treatment landscape.

Key Companies Profiled:

• Allergan plc
• Johnson & Johnson Vision
• TearLab Corporation
• Alcon Laboratories, Inc.
• Ocular Therapeutix, Inc.
• EyeGate Pharmaceuticals, Inc.
• Shire Pharmaceuticals
• Novartis AG
• Bausch & Lomb Incorporated
• Ciba Vision Corporation

Dry Eye Disease Treatment Devices Market Segmentation

By Product Type

• Meibomian Gland Unclogging Devices
• Wearable Devices
• Punctual Occlusion Devices
• Pain Relieving Devices

By Cause

• Idiopathic
• Rare Disease
• Surgery
• Drug Intake Associated
• Digital Exposure
• Age-Related

By Application

• Chronic Dry Eye
• Acute Dry Eye

By End User

• Hospitals and Clinics
• Home Care

By Region

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Dry Eye Disease Treatment Devices Market Snapshot, 2024-2031
• 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global GDP Growth Outlook
  • 2.3.2. Global Healthcare Industry Overview
• 2.4. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Product Type Lifecycle Analysis
• 3.2. Disease Epidemiology
• 3.3. Dry Eye Disease Treatment Devices Market: Value Chain
• 3.4. Parent Market Analysis
• 3.5. Covid-19 Impact Assessment
• 3.6. PESTLE Analysis
• 3.7. Porter Five Force's Analysis
• 3.8. Regulatory and Technology Landscape

4. Global Dry Eye Disease Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 4.1. Key Highlights
  • 4.1.1. Market Volume (Units) Projections
  • 4.1.2. Market Size and Y-o-Y Growth
  • 4.1.3. Absolute $ Opportunity
• 4.2. Market Size (US$ Mn) Analysis and Forecast
  • 4.2.1. Historical Market Size Analysis, 2019-2023
  • 4.2.2. Current Market Size Forecast, 2023-2031
• 4.3. Global Dry Eye Disease Treatment Devices Market Outlook: Product Type
  • 4.3.1. Introduction / Key Findings
  • 4.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Type, 2019-2023
  • 4.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
    • 4.3.3.1. Meibomian Gland Unclogging Devices
    • 4.3.3.2. Wearable Devices
    • 4.3.3.3. Punctual Occlusion Devices
    • 4.3.3.4. Pain Relieving Devices
    • 4.3.3.5. Others
• 4.4. Market Attractiveness Analysis: Product Type
• 4.5. Global Dry Eye Disease Treatment Devices Market Outlook: Cause
  • 4.5.1. Introduction / Key Findings
  • 4.5.2. Historical Market Size (US$ Mn) Analysis By Cause, 2019-2023
  • 4.5.3. Current Market Size (US$ Mn Forecast By Cause, 2024-2031
    • 4.5.3.1. Idiopathic
    • 4.5.3.2. Rare Disease
    • 4.5.3.3. Surgery
    • 4.5.3.4. Drug Intake Associated
    • 4.5.3.5. Digital Exposure
    • 4.5.3.6. Age-Related
• 4.6. Market Attractiveness Analysis: Cause
• 4.7. Global Dry Eye Disease Treatment Devices Market Outlook: Application
  • 4.7.1. Introduction / Key Findings
  • 4.7.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2023
  • 4.7.3. Current Market Size (US$ Mn Forecast By Application, 2024-2031
    • 4.7.3.1. Chronic Dry Eye
    • 4.7.3.2. Acute Dry Eye
• 4.8. Market Attractiveness Analysis: Application
• 4.9. Global Dry Eye Disease Treatment Devices Market Outlook: End Use
  • 4.9.1. Introduction / Key Findings
  • 4.9.2. Historical Market Size (US$ Mn) Analysis By End Use, 2019-2023
  • 4.9.3. Current Market Size (US$ Mn) Forecast By End Use, 2024-2031
    • 4.9.3.1. Hospitals and Clinics
    • 4.9.3.2. Home Care
• 4.10. Market Attractiveness Analysis: End Use

5. Global Dry Eye Disease Treatment Devices Market Outlook: Region

• 5.1. Key Highlights
• 5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2019-2023
• 5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2024-2031
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. East Asia
  • 5.3.4. South Asia and Oceania
  • 5.3.5. Latin America
  • 5.3.6. Middle East & Africa
• 5.4. Market Attractiveness Analysis: Region

6. North America Dry Eye Disease Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 6.1. Key Highlights
• 6.2. Pricing Analysis
• 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
  • 6.3.1. By Country
  • 6.3.2. By Product Type
  • 6.3.3. By Cause
  • 6.3.4. By Application
  • 6.3.5. By End Use
• 6.4. Current Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 6.4.1. U.S.
  • 6.4.2. Canada
• 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
  • 6.5.1. Meibomian Gland Unclogging Devices
  • 6.5.2. Wearable Devices
  • 6.5.3. Punctual Occlusion Devices
  • 6.5.4. Pain Relieving Devices
  • 6.5.5. Others
• 6.6. Current Market Size (US$ Mn) Forecast By Cause, 2024-2031
  • 6.6.1. Idiopathic
  • 6.6.2. Rare Disease
  • 6.6.3. Surgery
  • 6.6.4. Drug Intake Associated
  • 6.6.5. Digital Exposure
  • 6.6.6. Age-Related
• 6.7. Current Market Size (US$ Mn) Forecast By Application, 2024-2031
  • 6.7.1. Chronic Dry Eye
  • 6.7.2. Acute Dry Eye
• 6.8. Market Attractiveness Analysis
• 6.9. Current Market Size (US$ Mn) Forecast By End Use, 2024-2031
  • 6.9.1. Hospitals and Clinics
  • 6.9.2. Home Care
• 6.10. Market Attractiveness Analysis

7. Europe Dry Eye Disease Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 7.1. Key Highlights
• 7.2. Pricing Analysis
• 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
  • 7.3.1. By Country
  • 7.3.2. By Product Type
  • 7.3.3. By Cause
  • 7.3.4. By Application
  • 7.3.5. By End Use
• 7.4. Current Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 7.4.1. Germany
  • 7.4.2. France
  • 7.4.3. U.K.
  • 7.4.4. Italy
  • 7.4.5. Spain
  • 7.4.6. Russia
  • 7.4.7. Turkey
  • 7.4.8. Rest of Europe
• 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
  • 7.5.1. Meibomian Gland Unclogging Devices
  • 7.5.2. Wearable Devices
  • 7.5.3. Punctual Occlusion Devices
  • 7.5.4. Pain Relieving Devices
  • 7.5.5. Others
• 7.6. Current Market Size (US$ Mn) Forecast By Cause, 2024-2031
  • 7.6.1. Idiopathic
  • 7.6.2. Rare Disease
  • 7.6.3. Surgery
  • 7.6.4. Drug Intake Associated
  • 7.6.5. Digital Exposure
  • 7.6.6. Age-Related
• 7.7. Current Market Size (US$ Mn) Forecast By Application, 2024-2031
  • 7.7.1. Chronic Dry Eye
  • 7.7.2. Acute Dry Eye
• 7.8. Market Attractiveness Analysis
• 7.9. Current Market Size (US$ Mn) Forecast By End Use, 2024-2031
  • 7.9.1. Hospitals and Clinics
  • 7.9.2. Home Care
• 7.10. Market Attractiveness Analysis

8. East Asia Dry Eye Disease Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 8.1. Key Highlights
• 8.2. Pricing Analysis
• 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
  • 8.3.1. By Country
  • 8.3.2. By Product Type
  • 8.3.3. By Cause
  • 8.3.4. By Application
  • 8.3.5. By End Use
• 8.4. Current Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 8.4.1. China
  • 8.4.2. Japan
  • 8.4.3. South Korea
• 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
  • 8.5.1. Meibomian Gland Unclogging Devices
  • 8.5.2. Wearable Devices
  • 8.5.3. Punctual Occlusion Devices
  • 8.5.4. Pain Relieving Devices
  • 8.5.5. Others
• 8.6. Current Market Size (US$ Mn) Forecast By Cause, 2024-2031
  • 8.6.1. Idiopathic
  • 8.6.2. Rare Disease
  • 8.6.3. Surgery
  • 8.6.4. Drug Intake Associated
  • 8.6.5. Digital Exposure
  • 8.6.6. Age-Related
• 8.7. Current Market Size (US$ Mn) Forecast By Application, 2024-2031
  • 8.7.1. Chronic Dry Eye
  • 8.7.2. Acute Dry Eye
• 8.8. Market Attractiveness Analysis
• 8.9. Current Market Size (US$ Mn) Forecast By End Use, 2024-2031
  • 8.9.1. Hospitals and Clinics
  • 8.9.2. Home Care
• 8.10. Market Attractiveness Analysis

9. South Asia & Oceania Dry Eye Disease Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 9.1. Key Highlights
• 9.2. Pricing Analysis
• 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
  • 9.3.1. By Country
  • 9.3.2. By Product Type
  • 9.3.3. By Cause
  • 9.3.4. By Application
  • 9.3.5. By End Use
• 9.4. Current Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 9.4.1. India
  • 9.4.2. Southeast Asia
  • 9.4.3. ANZ
  • 9.4.4. Rest of South Asia & Oceania
• 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
  • 9.5.1. Meibomian Gland Unclogging Devices
  • 9.5.2. Wearable Devices
  • 9.5.3. Punctual Occlusion Devices
  • 9.5.4. Pain Relieving Devices
  • 9.5.5. Others
• 9.6. Current Market Size (US$ Mn) Forecast By Cause, 2024-2031
  • 9.6.1. Idiopathic
  • 9.6.2. Rare Disease
  • 9.6.3. Surgery
  • 9.6.4. Drug Intake Associated
  • 9.6.5. Digital Exposure
  • 9.6.6. Age-Related
• 9.7. Current Market Size (US$ Mn) Forecast By Application, 2024-2031
  • 9.7.1. Chronic Dry Eye
  • 9.7.2. Acute Dry Eye
• 9.8. Market Attractiveness Analysis
• 9.9. Current Market Size (US$ Mn) Forecast By End Use, 2024-2031
  • 9.9.1. Hospitals and Clinics
  • 9.9.2. Home Care
• 9.10. Market Attractiveness Analysis

10. Latin America Dry Eye Disease Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 10.1. Key Highlights
• 10.2. Pricing Analysis
• 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
  • 10.3.1. By Country
  • 10.3.2. By Product Type
  • 10.3.3. By Cause
  • 10.3.4. By Application
  • 10.3.5. By End Use
• 10.4. Current Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 10.4.1. Brazil
  • 10.4.2. Mexico
  • 10.4.3. Rest of Latin America
• 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
  • 10.5.1. Meibomian Gland Unclogging Devices
  • 10.5.2. Wearable Devices
  • 10.5.3. Punctual Occlusion Devices
  • 10.5.4. Pain Relieving Devices
  • 10.5.5. Others
• 10.6. Current Market Size (US$ Mn) Forecast By Cause, 2024-2031
  • 10.6.1. Idiopathic
  • 10.6.2. Rare Disease
  • 10.6.3. Surgery
  • 10.6.4. Drug Intake Associated
  • 10.6.5. Digital Exposure
  • 10.6.6. Age-Related
• 10.7. Current Market Size (US$ Mn) Forecast By Application, 2024-2031
  • 10.7.1. Chronic Dry Eye
  • 10.7.2. Acute Dry Eye
• 10.8. Market Attractiveness Analysis
• 10.9. Current Market Size (US$ Mn) Forecast By End Use, 2024-2031
  • 10.9.1. Hospitals and Clinics
  • 10.9.2. Home Care
• 10.10. Market Attractiveness Analysis

11. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 11.1. Key Highlights
• 11.2. Pricing Analysis
• 11.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
  • 11.3.1. By Country
  • 11.3.2. By Product Type
  • 11.3.3. By Cause
  • 11.3.4. By Application
  • 11.3.5. By End Use
• 11.4. Current Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 11.4.1. GCC
  • 11.4.2. Egypt
  • 11.4.3. South Africa
  • 11.4.4. Northern Africa
  • 11.4.5. Rest of Middle East & Africa
• 11.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
  • 11.5.1. Meibomian Gland Unclogging Devices
  • 11.5.2. Wearable Devices
  • 11.5.3. Punctual Occlusion Devices
  • 11.5.4. Pain Relieving Devices
  • 11.5.5. Others
• 11.6. Current Market Size (US$ Mn) Forecast By Cause, 2024-2031
  • 11.6.1. Idiopathic
  • 11.6.2. Rare Disease
  • 11.6.3. Surgery
  • 11.6.4. Drug Intake Associated
  • 11.6.5. Digital Exposure
  • 11.6.6. Age-Related
• 11.7. Current Market Size (US$ Mn) Forecast By Application, 2024-2031
  • 11.7.1. Chronic Dry Eye
  • 11.7.2. Acute Dry Eye
• 11.8. Market Attractiveness Analysis
• 11.9. Current Market Size (US$ Mn) Forecast By End Use, 2024-2031
  • 11.9.1. Hospitals and Clinics
  • 11.9.2. Home Care
• 11.10. Market Attractiveness Analysis

12. Competition Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. Market Structure
  • 12.2.1. Competition Intensity Mapping By Market
  • 12.2.2. Competition Dashboard
  • 12.2.3. Apparent Production Capacity
• 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 12.3.1. Johnson and Johnson Services Inc.
    • 12.3.1.1. Overview
    • 12.3.1.2. Segments and Products
    • 12.3.1.3. Key Financials
    • 12.3.1.4. Market Developments
    • 12.3.1.5. Market Strategy
  • 12.3.2. AbbVie Inc.
  • 12.3.3. Lumenis Be Ltd
  • 12.3.4. ESW-Vision
  • 12.3.5. Mibo Medical Group
  • 12.3.6. Sight Sciences.
  • 12.3.7. Eyedetect Medical Inc.
  • 12.3.8. BlephEx
  • 12.3.9. NuSight Medicals-Nulids LLC
  • 12.3.10. Others

13. Appendix

• 13.1. Research Methodology
• 13.2. Research Assumptions
• 13.3. Acronyms and Abbreviations